ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Who’s Going to ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
1,879 organizations and 4,162 speakers and poster presenters at the European Society for Medical Oncology (ESMO) Congress 2026, a ~37,000-person, mostly clinical congress of oncologists, cancer researchers and oncology biopharma teams. As of Nov 2, 2026.
| Organization | ESMO 2026 Attendance |
|---|---|
Gustave Roussy Villejuif, France | |
Comprehensive cancer centre in Villejuif, near Paris, France, affiliated with Paris-Saclay University. | Keynote Fri Oct 23 11:30–11:38 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Embedding co-creation to support immunotherapy de-escalation in the phase III OPT-PEMBRO trial in early triple-negative breast cancer Breast cancerNursing & supportive care Poster Fri Oct 23 13:00–15:00 Establishment and prospective evaluation of a national digital rare tumour advisory portal in Greece: A health services project in progress (TiP) Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 GIG-T (GETUG-T07): A phase 3 randomised study assessing thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 LEAH: A prospective multi-fluid cohort for cancer risk refinement and early detection Biomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Malnutrition, sarcopenia, hypermetabolism and micronutrient deficiencies at pancreatic cancer diagnosis: The NUTRIPAN cohort Gastrointestinal cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Moving beyond PD-L1: Immune microenvironment biomarkers associated with durable benefit from immune checkpoint inhibitors in cervical cancer Gynaecological cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Neoadjuvant-based multimodality treatment in rare sinonasal tumors: A single-center cohort Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Real-world data in adenoid cystic carcinoma: A retrospective single-center experience Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Chair Fri Oct 23 13:30–15:00 Abstract Fri Oct 23 14:00–14:10 Invited Discussant LBA23, LBA13 and LBA27 Breast cancer Talk Fri Oct 23 14:30–14:50 Therapeutic approaches in advanced/recurrent EC beyond CPIs and ADCs Gynaecological cancers Poster Fri Oct 23 15:15–16:00 A 25-gene T-cell exhaustion signature refines TLS-based prediction of immunotherapy benefit Lung & thoracic cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Characterization of the molecular and immune microenvironment landscape of synchronous vs metachronous renal cell carcinoma Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Genomic landscape and prognostic value of circulating tumor DNA (ctDNA) in pancreatic ductal adenocarcinoma (PDAC): A real-world cohort of 541 patients Gastrointestinal cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 In search for predictive biomarkers of redifferentiation treatment efficacy Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Prognostic value of the decipher prostate genomic classifier (GC) and neuroendocrine (NE) gene expression signatures in real-world de novo metastatic (M1) prostate cancer Genitourinary cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Poster Fri Oct 23 15:15–16:00 Talk Fri Oct 23 16:15–16:35 Novel AR targeted therapies Genitourinary cancers Abstract Fri Oct 23 16:25–16:37 Invited Discussant 1243RO and 1244RO Gynaecological cancers Talk Fri Oct 23 16:30–16:45 Basket trials: When is enough, enough? Biomarkers & precision oncology Talk Sat Oct 24 08:30–08:50 Talk Sat Oct 24 08:30–08:50 Presentation by Expert Genitourinary cancers Chair Sat Oct 24 08:30–10:00 Abstract Sat Oct 24 08:35–08:40 Talk Sat Oct 24 08:40–08:50 Welcome from ESMO Nursing & supportive care Talk Sat Oct 24 09:10–09:30 Systemic approach Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 09:15–09:25 Abstract Sat Oct 24 09:45–09:55 Invited Discussant 1457O, 1458O and 1459O Haematological malignancies Abstract Sat Oct 24 10:15–10:20 Talk Sat Oct 24 11:30–11:37 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Communicating complexity in precision oncology: Qualitative insights to inform patient-facing digital twins Biomarkers & precision oncology Chair Sat Oct 24 12:00–12:50 ESMO-EACR: What oncologists should know about molecular oncology Biomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Genomic landscape of hormone receptor positive bone-only (BO) and visceral metastases (VM) metastatic breast cancer (HR+ BC) Breast cancerBiomarkers & precision oncology Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Photobiomodulation as a novel strategy for toxicity prevention in head and neck cancer Sarcoma, CNS, head & neck and rare cancersNursing & supportive care Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Socio-economic factors (SEF) and use of supportive care (SC) in highly symptomatic patients (pts) with breast cancer (BC) Breast cancerNursing & supportive care Chair Sat Oct 24 12:00–12:50 What oncologists should know about managing toxicities of novel therapies Nursing & supportive care Poster Sat Oct 24 12:00–12:45 ctDNA-detected PIK3CA mutations identify endocrine resistance to CDK4/6 inhibitors in hormone receptor-positive positive metastatic breast cancer (HR+ MBC) Breast cancerBiomarkers & precision oncology Talk Sat Oct 24 12:15–12:30 Bispecifics Nursing & supportive care Talk Sat Oct 24 12:15–12:30 DNA repair Biomarkers & precision oncology Satellite Sat Oct 24 14:05–14:17 Nuclear Medicine: partner for the Prostate Cancer journey Genitourinary cancers Chair Sat Oct 24 14:45–16:15 Emerging toxicities induced by antibody-drug conjugates Nursing & supportive care Talk Sat Oct 24 14:45–15:10 Pulmonary toxicities Nursing & supportive care Talk Sat Oct 24 15:00–15:15 Pheochromocytoma and paraganglioma Sarcoma, CNS, head & neck and rare cancers Talk Sat Oct 24 15:15–15:35 How will new technologies contribute to precision medicine? Biomarkers & precision oncology Talk Sat Oct 24 15:20–15:35 View of the interventional radiologist Gastrointestinal cancers Talk Sat Oct 24 15:45–16:05 NUT carcinomas, salivary gland cancers and pulmonary blastomas Lung & thoracic cancers Talk Sat Oct 24 15:45–16:05 What to do after optimal neoadjuvant therapy? Breast cancer Chair Sat Oct 24 16:30–18:15 Presidential Symposium I Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers Satellite Sat Oct 24 18:30–20:00 Ipsen - Treatment decisions that shape the journey in RCC and NETs Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 18:30–18:33 Welcome Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 18:33–18:43 Sequencing in an ever-changing landscape (RCC and NETs) Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 18:43–19:23 Navigating the RCC treatment journey Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Talk Sun Oct 25 08:30–08:35 Chair Sun Oct 25 08:30–10:00 Rapid oral 2: NSCLC, metastatic Lung & thoracic cancers Chair Sun Oct 25 08:30–10:00 Chair Sun Oct 25 08:30–09:45 Abstract Sun Oct 25 08:35–08:40 4245RO - Complementary roles of liquid biopsy and imaging in assessing tumor burden in metastatic cancer Biomarkers & precision oncology Abstract Sun Oct 25 08:45–08:57 Talk Sun Oct 25 08:55–09:15 Abstract Sun Oct 25 08:57–09:02 Abstract Sun Oct 25 09:29–09:44 Invited Discussant 2618RO, 2652RO and 2680RO Lung & thoracic cancers Chair Sun Oct 25 10:15–11:45 Chair Sun Oct 25 10:15–11:45 Chair Sun Oct 25 10:15–11:45 Emerging new systemic therapies for RCC Genitourinary cancers Talk Sun Oct 25 10:15–10:35 Novel HIF2a targeted agents and combination strategies Genitourinary cancers Talk Sun Oct 25 10:45–11:00 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Satellite Sun Oct 25 13:05–13:15 Building Bridges in the Management of CSCC Melanoma & skin cancers Satellite Sun Oct 25 13:10–13:40 Satellite Sun Oct 25 13:15–13:35 Resectable or Not: Navigating the Gray Zones in Advanced CSCC Melanoma & skin cancers Satellite Sun Oct 25 13:35–13:50 Defining High-risk CSCC: Identifying Patients Who Need More Melanoma & skin cancers Satellite Sun Oct 25 13:40–13:45 Audience Q&A: Advanced prostate cancer Genitourinary cancers Talk Sun Oct 25 13:45–14:00 Satellite Sun Oct 25 13:50–14:20 Timing and Selection of Systemic Therapy in Resectable CSCC Melanoma & skin cancers Satellite Sun Oct 25 14:20–14:30 Audience Q&A Melanoma & skin cancers Chair Sun Oct 25 14:45–16:25 Talk Sun Oct 25 15:10–15:30 Neoadjuvant therapy: A global prescription for cure Melanoma & skin cancers Abstract Sun Oct 25 15:44–15:49 1538RO - First interim safety analysis of GORTEC 2024-03 IDEAL: Randomized phase II trial of induction treatment anti–PD-1 pucotenlimab (HX008) plus EGFR-ADC (becotatug vedotin (MRG003) versus EGFR-ADC alone followed by chemoradiotherapy in locally advanced head and neck squamous cell carcinoma Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 15:44–15:49 Abstract Sun Oct 25 16:05–16:15 Talk Sun Oct 25 16:30–16:55 Abstract Sun Oct 25 16:42–16:54 Invited Discussant LBA5 Lung & thoracic cancersGastrointestinal cancers Talk Mon Oct 26 08:30–08:50 Chair Mon Oct 26 08:30–10:00 Chair Mon Oct 26 08:30–10:00 Navigating the wave of new therapies in gynaecologic cancers Gynaecological cancers Abstract Mon Oct 26 08:40–08:50 Talk Mon Oct 26 09:10–09:30 Abstract Mon Oct 26 09:38–09:50 Invited Discussant 3084O, 3893O and 3894O Nursing & supportive care Chair Mon Oct 26 10:15–11:45 Addressing the risk of second primary cancers Nursing & supportive care Chair Mon Oct 26 10:15–11:45 Talk Mon Oct 26 10:40–11:05 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Liquid biopsy in fusion-driven NSCLC: Informative rates, resistance detection, and clinical impact Lung & thoracic cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Systemic proteomics and muscle programs associated with cachexia in resectable head and neck cancer Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Mon Oct 26 12:00–12:45 Talk Mon Oct 26 13:25–13:35 Talk Mon Oct 26 13:35–13:37 Abstract Mon Oct 26 14:45–14:50 Chair Mon Oct 26 14:45–15:45 Chair Mon Oct 26 14:45–16:15 Proffered paper: Non-metastatic NSCLC and other thoracic malignancies Lung & thoracic cancers Abstract Mon Oct 26 14:50–14:55 Abstract Mon Oct 26 15:07–15:12 Talk Mon Oct 26 15:10–15:25 How to simplify the algorithm of treatment of rare endocrine tumors Sarcoma, CNS, head & neck and rare cancers Abstract Mon Oct 26 15:53–16:05 Invited Discussant LBA64, 2519O and 2511O Lung & thoracic cancers Chair Mon Oct 26 16:30–17:45 Chair Mon Oct 26 16:30–18:00 IO-based systemic therapy in head and neck cancers Sarcoma, CNS, head & neck and rare cancers Talk Mon Oct 26 16:30–16:35 Presentation of case/condition Nursing & supportive care Abstract Mon Oct 26 16:42–16:54 Invited Discussant LBA9 Gynaecological cancersSarcoma, CNS, head & neck and rare cancers Chair Tue Oct 27 09:00–13:00 Talk Tue Oct 27 12:40–13:00 |
Find buyers from organizations at ESMO 2026
Tell us what you sell and we’ll find the people at these organizations most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
When and where was ESMO 2026?
ESMO Congress 2026 ran October 23–27, 2026, at IFEMA Madrid in Madrid, Spain.
What conference is this?
The ESMO Congress is the European Society for Medical Oncology’s annual meeting, held October 23–27, 2026 at IFEMA in Madrid — Europe’s largest oncology congress, with about 37,000 participants. It brings together medical oncologists, cancer researchers, oncology nurses and the pharma, biotech and diagnostics companies that serve them, across educational sessions, proffered-paper and rapid-oral abstract sessions, special symposia, industry satellite symposia and an exhibition.
What is in this guide?
Every organization we can place at ESMO 2026: the institutions of 4,162 faculty, chairs and presenting authors from the Final Programme (1,775 sessions and talks) and ESMO’s poster records (3,905 posters), plus the 235 exhibitors and 6 more industry satellite sponsors — 1,879 organizations in one list. People appear as a count, never by name.
Where do the posters come from?
From ESMO’s own public session data, the records behind esmo.org, whose poster authors’ affiliations were released in October. Each record gives the poster’s title, session and tumour-site tags, the presenting author and the numbered affiliations, and 3,905 posters across 50 poster sessions are listed here under 3,249 presenting authors’ institutions. A poster counts only its presenting author’s institution, never its co-authors’. About 630 poster records carry no abstract or institution and look withdrawn, and 99 name a presenting author we could not tie to an institution; those are left out. Abstract text is not shown here: open the session on ESMO’s own planner.
How are organizations typed?
By the role an organization plays in cancer care and oncology drug development: drug developers (large pharma and biotech), diagnostics and tools, CROs, medical education and other services, cancer centres and hospitals, universities and institutes, and societies and non-profits. The tumour-type filters come from ESMO’s own tumour-site tags on each session and poster, and otherwise from its title.
How current is it?
Pulled on November 2, 2026, after the congress: the ESMO Congress 2026 Final Programme of that day, ESMO’s public session and poster data, and the Exhibitor List.
Browse ESMO 2026 by
Organizations with their own page
692 organizations — every exhibitor and every organization with 3 or more presentations.
- 1Cell.Ai
- 3DHISTECH
- A Coruña University Hospital (CHUAC)
- A.C. Camargo Cancer Center
- Aarhus University Hospital
- Abbott
- AbbVie
- ABC Global Alliance
- Abderrahmen Mami Pneumo-Phthisiology Hospital
- Abramson Cancer Center
- Accord Healthcare
- Adnan Menderes University Training and Research Hospital
- Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
- AdventHealth Cancer Institute
- Aga Khan University Hospital
- Agendia
- Agilent Technologies
- Aignostics
- Akeso
- Al-Quds University
- Alexandra Hospital
- Alexandria University
- All India Institute of Medical Sciences
- Allucent
- American Association for Cancer Research (AACR)
- American Society of Clinical Oncology (ASCO)
- American University of Beirut Medical Center
- Amgen
- Amoy Diagnostics (AmoyDx)
- Amsterdam UMC
- Andijan State Medical Institute
- Ankara Etlik City Hospital
- Ankara University
- Answers in CME
- Antalya Training and Research Hospital
- Antwerp University Hospital (UZA)
- APICES
- APLUSA
- Aptitude Health
- ArriVent BioPharma
- Arthur Child Comprehensive Cancer Centre
- Asan Medical Center
- ASST Spedali Civili di Brescia
- Astellas
- Aston University
- AstraZeneca
- Attikon University Hospital
- August Pi i Sunyer Biomedical Research Institute (IDIBAPS)
- Aurevia
- Axiom Healthcare Strategies
- AXS Studio
- Banook Group
- Barts Cancer Centre
- Barts Cancer Institute, Queen Mary University of London
- Basingstoke and North Hampshire Hospital
- Bayer
- Başkent University
- BC Cancer
- BD (Becton, Dickinson and Company)
- Beacon Pharmaceuticals
- Beatson West of Scotland Cancer Centre
- Beaumont Hospital
- Beijing Obstetrics and Gynecology Hospital
- Beijing Tiantan Hospital
- Beijing Tongren Hospital
- Belarusian State Medical University
- BeOne Medicines
- Bicara Therapeutics
- Biobizkaia Health Research Institute
- BioNTech
- Biorray Genetics
- Blokhin National Medical Research Center of Oncology
- Boehringer Ingelheim
- Brand Institute
- Brazilian National Cancer Institute (INCA)
- Brigham and Women's Hospital
- Bristol Myers Squibb
- Burjeel Medical City
- Burning Rock Dx
- Caidya
- Cambridge University Hospitals
- Campus Bio-Medico University Hospital
- Cancer Hospital, Chinese Academy of Medical Sciences Shenzhen Center
- Cancer Institute Hospital of JFCR
- Cancer Patients Europe
- Cancer Research UK
- Cardiff University
- Careggi University Hospital
- Caris Life Sciences
- Catalan Institute of Oncology (ICO)
- Catalysis
- Cedars-Sinai Medical Center
- Celcuity
- Center for Innovation in Medicine
- CENTOGENE
- Centre Antoine Lacassagne
- Centre Eugène Marquis
- Centre François Baclesse
- Centre Hospitalier de l’Université de Montréal
- Centre Jean Perrin
- Centre Léon Bérard
- Centre Oscar Lambret
- Centro de Tratamiento e Investigación sobre Cáncer (CTIC)
- Centro di Riferimento Oncologico di Aviano (CRO)
- Cerba Research
- Champalimaud Foundation
- Changhai Hospital
- Charité – Universitätsmedizin Berlin
- Chelsea and Westminster Hospital
- Chinese Medical Journal
- Chinese PLA General Hospital
- Chongqing University Cancer Hospital
- Chronomics
- CHU de Besançon
- CIOCC - Centro Integral Oncológico Clara Campal
- City of Hope
- Clario
- Cliniques universitaires Saint-Luc
- Clínica Universidad de Navarra
- Cogent Biosciences
- Compass Therapeutics
- Connect by Circular-Lab
- Copenhagen University Hospital – Herlev
- COR2ED
- Corcept Therapeutics
- Costello Medical
- CREATION.co
- Crescent Biopharma
- Cureety
- Cyprus University of Technology
- Daiichi Sankyo
- Damascus University
- Dana-Farber Cancer Institute
- Datar Cancer Genetics
- Deciphera Pharmaceuticals
- Delcath Systems
- Dermophisiologique
- Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Dr. Reddy's Laboratories
- Duke-NUS Medical School
- Eindhoven University of Technology
- Eisai
- Elevar Therapeutics
- Eli Lilly
- Elsevier
- Emerald Clinical Trials
- Erasmus MC
- Ergomed
- Eskayef Pharmaceuticals
- Eurobio Scientific
- European Institute of Oncology (IEO)
- European Organisation for Research and Treatment of Cancer (EORTC)
- European Society for Medical Oncology (ESMO)
- Evangelische Kliniken Essen-Mitte
- Ewha Womans University Mokdong Hospital
- Exelixis
- Flatiron Health
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Fore Biotherapeutics
- Fortis Memorial Research Institute
- Fortrea
- Fortvita Biologics
- Fred & Pamela Buffett Cancer Center
- Frontiers in Oncology
- Fudan University Shanghai Cancer Center
- Fujian Cancer Hospital
- Fulgent Genetics
- Fundación Santa Fe de Bogotá
- Gangnam Severance Hospital
- Gazi University
- Gene Solutions
- Genecast
- GeneCker
- Genes2Me
- Geneseeq
- Genetron Health
- Geneva University Hospitals (HUG)
- Genmab
- Gentili
- Georgetown Lombardi Comprehensive Cancer Center
- German Breast Group (GBG)
- German Cancer Research Center (DKFZ)
- German Oncology Center
- Ghent University
- Ghent University Hospital
- Giftshed
- Gilead Sciences
- Girona Biomedical Research Institute (IDIBGI)
- Gosta Labs
- Greater Manchester Cancer Academy
- GSK
- Guangdong Provincial People's Hospital
- Guardant Health
- Gustave Roussy
- Guy's and St Thomas' NHS Foundation Trust
- Hacettepe University
- Hannover Medical School
- Hanyang University
- Harvard Chan School of Public Health
- Harvard Medical School
- Hassan II University Hospital
- Hasselt University
- Hedera Dx
- Heidelberg University
- Heidelberg University Hospital
- Helsinn
- Hema.to
- Henan Cancer Hospital
- Hengrui Pharma
- Henri-Mondor University Hospital
- Henry Dunant Hospital Center
- Hertsen Moscow Oncology Research Institute
- HighField Biopharmaceuticals
- Hilotherm
- Himalayan Institute of Medical Sciences
- HistoSonics
- Hoag Family Cancer Institute
- Hospices Civils de Lyon
- Hospital 9 de Julho
- Hospital Arnau de Vilanova
- Hospital Clínic de Barcelona
- Hospital Clínico San Carlos
- Hospital Clínico Universitario de Valencia
- Hospital de Amor
- Hospital de Faro
- Hospital de la Santa Creu i Sant Pau
- Hospital de Santa Maria
- Hospital del Mar
- Hospital General Universitario Gregorio Marañón
- Hospital General Universitario Morales Meseguer
- Hospital Israelita Albert Einstein
- Hospital Italiano de Buenos Aires
- Hospital La Luz
- Hospital Moinhos de Vento
- Hospital Sírio-Libanês
- Hospital Universitari i Politècnic La Fe
- Hospital Universitario 12 de Octubre
- Hospital Universitario de la Princesa
- Hospital Universitario de Navarra
- Hospital Universitario Fundación Jiménez Díaz
- Hospital Universitario La Paz
- Hospital Universitario Puerta de Hierro Majadahonda
- Hospital Universitario Ramón y Cajal
- Hospital Universitario Virgen de la Victoria
- Humanitas Research Hospital
- Humanitas University
- Hunan Cancer Hospital
- Huntsman Cancer Institute
- Hôpital Cochin (AP-HP)
- Hôpital Européen Georges-Pompidou
- Hôpital Saint-Louis (AP-HP)
- Icahn School of Medicine at Mount Sinai
- ICON
- IDEAYA Biosciences
- IDOMED
- IFOM
- IKF
- Illumina
- Imagene AI
- Imaging Endpoints
- Immunai
- ImmunityBio
- Immunocore
- Immunome
- Imperial College London
- Incheon St. Mary's Hospital (The Catholic University of Korea)
- Incyte
- Inhibrx Biosciences
- Inizio
- Institut Bergonié
- Institut Curie
- Institut de Cancérologie de l'Ouest
- Institut de Cancérologie de Lorraine
- Institut Jules Bordet
- Institut National d'Oncologie Sidi Mohamed Ben Abdellah
- Institut Paoli-Calmettes
- Institut Strauss
- Institute of Oncology Research (IOR)
- Instituto do Câncer do Estado de São Paulo (ICESP)
- Instituto Nacional de Cancerología (INCan)
- IntegraGen
- International Cancer Foundation
- International Society of Liquid Biopsy
- iNtRON Biotechnology
- Iovance Biotherapeutics
- iProcess Global Research
- Ipsen
- IQVIA
- IRCCS Institute of Neurological Sciences of Bologna
- IRST Dino Amadori
- Isala
- Istanbul Kartal Dr. Lütfi Kırdar City Hospital
- Istanbul University Institute of Oncology
- Istanbul University-Cerrahpaşa
- Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
- Istituto Oncologico Veneto (IOV)
- IUCT-Oncopole
- Jazz Pharmaceuticals
- Jersey Shore University Medical Center
- Jewish General Hospital
- Jiangsu Province Hospital
- Johns Hopkins University
- Johnson & Johnson
- K Hospital
- Kanagawa Cancer Center
- Kantonsspital St. Gallen
- Kapadi
- Karolinska Institutet
- Karolinska University Hospital
- Kasturba Medical College
- Kauno Klinikos
- Kazakh Research Institute of Oncology and Radiology
- Keelung Chang Gung Memorial Hospital
- Keio University
- King Hussein Cancer Center
- King's College London
- Klinikum Ernst von Bergmann
- Klinikum Stuttgart
- KoNECT & KHIDI
- Korea University
- Korea University Anam Hospital
- Koç University Hospital
- Krankenhaus Nordwest
- Kravira Medical Centre
- KVR Multi Speciality Hospital
- Kyushu University
- LabConnect
- Labcorp
- Latin American Cooperative Oncology Group
- Lausanne University Hospital (CHUV)
- LeCancer.fr
- Legorreta Cancer Center
- Leiden University Medical Center
- Liaoning Cancer Hospital and Institute
- Lifescience Dynamics
- Lille University Hospital
- Limoges University Hospital
- Lincoln Medical Center
- Linkou Chang Gung Memorial Hospital
- LMU Munich
- LMU University Hospital Munich
- Lumara Bio
- Lunit
- Maastricht UMC+
- Maria Sklodowska-Curie National Research Institute of Oncology
- Maria Skłodowska-Curie National Research Institute of Oncology, Kraków Branch
- Marseille Cancer Research Center (CRCM)
- Masaryk Memorial Cancer Institute
- Massachusetts General Hospital
- Massive Bio
- Mayo Clinic
- MD Anderson Cancer Center
- MDPI
- Med Learning Group
- Median Technologies
- Medical Genetics Institute
- Medical University of Gdansk
- Medical University of Graz
- Medical University of Innsbruck
- Medical University of Vienna
- Mediclinic City Hospital
- Medicover Genetics
- Medidata
- Medpace
- Medscape
- Medtronic
- Melanoma Institute Australia
- Memorial Sloan Kettering Cancer Center
- Menarini Stemline
- Merck KGaA
- MERIT
- METHYS Dx
- Metropolitan Hospital
- MFAR Clinical Research
- Miami Cancer Institute
- Miguel Servet University Hospital
- Military Hospital of Tunis
- Miltenyi Biotec
- Moderna
- Moffitt Cancer Center
- Mount Vernon Cancer Centre
- MSD
- Myriad Genetics
- myTomorrows
- Nagoya City University
- Nanjing Drum Tower Hospital
- Natera
- National and Kapodistrian University of Athens
- National Autonomous University of Mexico
- National Cancer Center Hospital
- National Cancer Center Hospital East
- National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences
- National Cancer Centre Singapore
- National Cancer Institute, Cairo
- National Center for Tumor Diseases Heidelberg
- National Institute of Neoplastic Diseases
- National Network Genomic Medicine
- National Taiwan University
- National Taiwan University Cancer Center
- National University Cancer Institute, Singapore
- Necmettin Erbakan University Meram Medical Faculty
- NeoGenomics
- Nestlé
- Netherlands Cancer Institute
- Netherlands Comprehensive Cancer Organisation (IKNL)
- New Cross Hospital
- NEXT Oncology
- Nimmagadda Multi Specialty Hospital
- Noah AI
- Northwell Health
- Northwestern University
- Nottingham City Hospital
- Novartis
- Novocure
- Novotech
- Nuvation Bio
- OAE Publishing
- Odense University Hospital
- OncLive
- ONCOassist
- Oncoclínicas
- OncoDNA
- Oncology Institute of Southern Switzerland (IOSI)
- Oncomedics
- Oncoscope
- OPEN Health
- Orakl Oncology
- ORIC Pharmaceuticals
- Orion Pharma
- Oslo University Hospital
- Oxford University Hospitals NHS Foundation Trust
- Oxon Epidemiology
- PamDx
- Parexel
- PathAI
- Patholytix
- Paxman
- PEAK Medicals
- PeerView
- PeerVoice
- Peking Union Medical College Hospital
- Peking University Cancer Hospital
- Peking University First Hospital
- Peking University People's Hospital
- PentaBase
- Perceptive
- Personalis
- Peter MacCallum Cancer Centre
- Pfizer
- Pharmadab
- PharmaMar
- Pharmetheus
- Physicians' Education Resource (PER)
- Pierre Fabre
- Pillar Biosciences
- Pitié-Salpêtrière Hospital
- PIVOTAL
- Policlinico San Matteo
- Policlinico Universitario Agostino Gemelli
- Politecnico di Milano
- Portuguese Institute of Oncology of Lisbon
- Portuguese Oncology Institute of Porto
- Precision for Medicine
- Predicine
- Premier Research
- Prestige Biopharma
- Princess Alexandra Hospital
- Princess Margaret Cancer Centre
- PSI CRO
- Qilu Hospital of Shandong University
- QPS
- Queen Elizabeth Hospital
- Queen's University
- Quest Diagnostics
- Quibim
- Qure.ai
- Radboud University Medical Center
- Ramathibodi Hospital
- Rambam Health Care Campus
- RAND
- Rapidus MR
- RayzeBio
- RBC Bioscience
- Regeneron
- Regina Elena National Cancer Institute
- Relay Therapeutics
- Renata
- Renji Hospital
- Resilience Care
- Revolution Medicines
- Rhode Island Hospital
- Rigshospitalet (Copenhagen University Hospital)
- Roche
- Rosebank Oncology Clinical and Translational Research Unit
- Royal Berkshire Hospital
- Ruijin Hospital
- Rutgers Cancer Institute
- Salah Azaiez Institute
- Salamanca University Hospital Complex
- Samsung Advanced Institute for Health Sciences and Technology
- Samsung Medical Center
- San Giovanni di Dio Hospital
- San Luigi Gonzaga University Hospital
- San Raffaele Hospital
- Sanofi
- Sant'Andrea University Hospital
- Sant'Orsola-Malpighi University Hospital
- Santa Maria Annunziata Hospital
- Santa Maria delle Grazie Hospital
- Santiago de Compostela University Clinical Hospital
- Sapienza University of Rome
- Sarah Cannon Research Institute
- Semmelweis University
- Seoul National University Hospital
- Servier
- Sestre milosrdnice University Hospital Centre
- Shandong Cancer Hospital
- Shandong Provincial Hospital
- Shanghai Chest Hospital
- Shanghai East Hospital
- Shanghai Eastern Hepatobiliary Surgery Hospital
- Shanghai Ninth People's Hospital
- Shanghai Pulmonary Hospital
- Shanxi Provincial Cancer Hospital
- Sheba Medical Center
- Sichuan Cancer Hospital and Institute
- Siemens Healthineers
- SimSen Diagnostics
- Sir Run Run Shaw Hospital
- SmartCatch
- SOPHiA GENETICS
- Sotiria Thoracic Diseases Hospital of Athens
- Southeast University
- Spanish National Cancer Research Centre (CNIO)
- Spanish Society of Medical Oncology (SEOM)
- Springer Medicine
- Sqilline Health
- Sri Shankara Cancer Hospital and Research Centre
- St Bartholomew's Hospital
- St James's Hospital
- St Vincent's University Hospital
- Stanford University
- START Center for Cancer Care
- STCube Pharmaceuticals
- Summit Therapeutics
- Sun Pharma
- Sun Yat-sen Memorial Hospital
- Sun Yat-sen University Cancer Center
- Sunnybrook Health Sciences Centre
- Syncromune
- Syneos Health
- Sysmex
- Taichung Veterans General Hospital
- Taipei Medical University
- Takeda
- Tampere University Hospital
- Tata Memorial Hospital
- Tel Aviv Sourasky Medical Center
- Telix Pharmaceuticals
- Tempus
- TFS HealthScience
- The Chinese University of Hong Kong
- The Christie
- The Clatterbridge Cancer Centre
- The First Affiliated Hospital of Guangzhou Medical University
- The First Affiliated Hospital of Xi'an Jiaotong University
- The First Affiliated Hospital of Zhejiang University School of Medicine
- The First Hospital of Jilin University
- The Fourth Hospital of Hebei Medical University
- The Francis Crick Institute
- The Institute of Cancer Research
- The Kinghorn Cancer Centre
- The Ohio State University Comprehensive Cancer Center – James
- The Ohio State University Wexner Medical Center
- The Open University
- The Ottawa Hospital Cancer Centre
- The Royal Marsden
- The Second Affiliated Hospital of Zhejiang University School of Medicine
- The University of Adelaide
- The University of British Columbia
- The University of Hong Kong
- The University of Manchester
- Therakos
- Thermo Fisher Scientific
- Tianjin Medical University Cancer Institute and Hospital
- Tigermed
- Tongji Hospital (Tongji Medical College, HUST)
- TORL BioTherapeutics
- Translational Research in Oncology (TRIO)
- Trinity College Dublin
- Trinity St James's Cancer Institute
- TU Dresden
- TUM University Hospital
- Tung Wah College
- Turbine
- UC Davis Comprehensive Cancer Center
- Ulm University Hospital
- Unicancer
- Union Hospital (Tongji Medical College, HUST)
- University College Cork
- University College London
- University College London Hospitals
- University Hospital Basel
- University Hospital Bonn
- University Hospital Centre Zagreb
- University Hospital Cologne
- University Hospital Düsseldorf
- University Hospital Erlangen
- University Hospital Essen
- University Hospital Leipzig
- University Hospital Münster
- University Hospital of Parma
- University Hospital of the Canary Islands
- University Hospital RWTH Aachen
- University Hospital Schleswig-Holstein
- University Hospital Tübingen
- University Hospital Zurich
- University Hospitals Birmingham
- University Hospitals Leuven
- University Hospitals Seidman Cancer Center
- University Medical Center Groningen
- University Medical Center Hamburg-Eppendorf
- University Medical Center of Johannes Gutenberg University Mainz
- University Medical Center Utrecht
- University Medical Centre Mannheim
- University of Bologna
- University of Calgary
- University of California San Diego
- University of California, Los Angeles (UCLA)
- University of California, San Francisco (UCSF)
- University of Cambridge
- University of Campania Luigi Vanvitelli
- University of Campinas
- University of Chicago
- University of Colorado Anschutz Medical Campus
- University of Edinburgh
- University of Genoa
- University of Glasgow
- University of Gothenburg
- University of Health Sciences Türkiye
- University of Leeds
- University of Miami
- University of Milan
- University of Modena and Reggio Emilia
- University of Naples Federico II
- University of New South Wales
- University of Oxford
- University of Padua
- University of Palermo
- University of Pisa
- University of Pittsburgh
- University of Southampton
- University of Southern California
- University of Sydney
- University of Toronto
- University of Turin
- University of Verona
- University of Washington
- Università Cattolica del Sacro Cuore
- Université Paris-Saclay
- UPMC Hillman Cancer Center
- UZ Brussel
- Vall d'Hebron Institute of Oncology (VHIO)
- Vall d'Hebron University Hospital
- Vanderbilt-Ingram Cancer Center
- Velindre Cancer Centre
- Veracyte
- Vicomtech
- Virgen del Rocío University Hospital
- VJOncology
- Waiv
- Washington University in St. Louis
- Weill Cornell Medicine
- West China Hospital, Sichuan University
- Winship Cancer Institute of Emory University
- Wisepress Medical Bookshop
- Wolters Kluwer
- World Health Organization
- Worldwide Clinical Trials
- XYone Therapeutics
- Yale University
- Yeolyan Hematology and Oncology Center
- Yerevan State Medical University
- Yonsei Cancer Center
- Yonsei University
- Yourgene Health
- ZAS (Ziekenhuis aan de Stroom)
- Zentalis Pharmaceuticals
- Zhejiang Cancer Hospital
- Zhejiang Provincial People's Hospital
- Zhongshan Hospital, Fudan University
- Çukurova University
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction